European Archives - Page 1054 of 1157 - European Medical Journal

EMJ

Translating cancer immunotherapy to the clinic

At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Sergio Quezada, PhD, from University College London, London, UK, discusses…

EMJ

ESMO Asia 2015 Congress

LUGANO/SINGAPORE, 16 December 2015 – ESMO, the leading professional organisation for medical oncology, is pleased to announce the inaugural ESMO Asia…

EMJ

Latin American Migrants in Spain Should Be Screened for Chagas Disease

Seville, Spain – 5 December 2015: Latin American migrants in Spain should be screened for Chagas disease, particularly women before pregnancy…

EMJ

Can Cancer Itself Damage the Heart?

Seville, Spain – 3 December 2015: Research presented today at EuroEcho-Imaging 2015 raises the possibility that cancer itself may damage heart muscle…

EMJ

New SEER Registry “Big Data” Demonstrates the Oncotype DX® Test Accurately Predicts Clinical Breast Cancer Outcomes, Bringing the Total Number of Patients in Prospective Outcome Studies to 50,000

GENEVA, Switzerland, [December 14, 2015] – Genomic Health today announced results from multiple Oncotype DX® breast cancer test studies at the…

Achieving Treatment Goals in Inflammatory Bowel Disease: The Role of Gut-Selective Therapy

Despite major advances in the inflammatory bowel disease (IBD) treatment landscape, the management of ulcerative colitis (UC) and Crohn’s disease (CD)…

Biologic Therapies: From Complexity to Clinical Practice in a Changing Environment

This symposium provided an opportunity for global experts to discuss the challenges posed by the introduction of biosimilars. The impact of the…

The Full Picture of Ulcerative Colitis: The Burden, the Patient, the Treatment

Ulcerative colitis (UC) carries a significant, progressive disease burden that is often underestimated or misinterpreted by healthcare providers.

Gut Microbiota: Modulate its Complexity to Restore the Balance

The importance of the gut microbiota to health is becoming more widely appreciated. The range of commensal microorganisms in healthy individuals and in…

Cystic Pancreatic Lesions Beyond the Guidelines: Can we Make an Evidence-Based Decision Whether to Resect or to Observe?

Pancreatic cystic neoplasms (PCNs) are no longer considered as rare entities because their prevalence in the general population ranges from 3–20%.